Financials
Lumentum is undergoing a structural inflection driven by AI optical infrastructure demand. Revenue
accelerated from +16% to +90% YoY over 5 quarters, with non-GAAP operating margins expanding
+3,250 bps (from -0.3% to 32.2%) over 8 quarters. The balance sheet transformed from ~$2B net debt
to ~$2.6B net cash via NVIDIA's $2B strategic investment and convertible note conversions. FCF
inflected positive in CQ1 2026 ($79M) after two years of negative FCF driven by aggressive CapEx
investment. Management targets $2B quarterly revenue within 18-24 months.
CQ1 '26 Revenue
$808.4M
+90.1% YoY | +21.5% QoQ
Non-GAAP Op Margin
32.2%
+3,250 bps from trough | Surpassed prior peak
CQ1 '26 Adj EBITDA
$293.5M
36.3% margin | 7x trough quarter
Net Cash Position
~$2.6B
From ~$2B net debt in FY2024
Annual Financial Summary ($M, FY ends ~June)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1,742.8M | $1,712.6M | $1,767.0M | $1,359.2M | $1,645.0M |
| Rev YoY | — | -1.7% | +3.2% | -23.1% | +21.0% |
| Non-GAAP Gross Margin | 50.9% | 51.6% | 43.2% | 33.0% | 34.7% |
| Non-GAAP Op Margin | 30.8% | 30.8% | 19.2% | 2.8% | 9.7% |
| Non-GAAP EPS | $6.31 | $6.05 | $4.56 | $1.01 | $2.06 |
| Adj EBITDA | $621.0M | $608.6M | $431.7M | $140.5M | $264.2M |
| FCF | $653.9M | $368.1M | $51.3M | ($108.3M) | ($104.7M) |
| Diluted Shares (M) | 78.4M | 74.2M | 68.3M | 67.3M | 69.6M |
Note: Fiscal year ends late June. Revenue CAGR FY2021-FY2025 of -1.4% is misleading -- reflects a severe cyclical trough (FY2024, -23% YoY from telecom destocking) followed by an AI-driven recovery. Non-GAAP metrics exclude SBC, amortization of acquired intangibles, and restructuring charges.
Non-GAAP gross margins compressed from ~51% (FY2021-22) to 33% at the cyclical trough (FY2024), then began recovering to 34.7% in FY2025. The annual figures understate the recovery -- the quarterly trajectory shows margins expanding from 32.2% to 47.9% over 8 quarters. Operating margins followed the same arc: 30.8% peak to 2.8% trough to 9.7% initial recovery, with Q3 FY2026 already at 32.2%, surpassing the prior peak.
Quarterly Financial Trajectory (CQ1 2024 -- CQ1 2026)
| Metric | CQ1 '24 | CQ2 '24 | CQ3 '24 | CQ4 '24 | CQ1 '25 | CQ2 '25 | CQ3 '25 | CQ4 '25 | CQ1 '26 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $366.5M | $308.3M | $336.9M | $402.2M | $425.2M | $480.7M | $533.8M | $665.5M | $808.4M |
| QoQ Growth | — | -15.9% | +9.3% | +19.4% | +5.7% | +13.1% | +11.0% | +24.7% | +21.5% |
| YoY Growth | — | — | — | — | +16.0% | +55.9% | +58.4% | +65.3% | +90.1% |
| Non-GAAP GM | 32.6% | 32.2% | 32.8% | 32.3% | 35.2% | 37.8% | 39.4% | 42.5% | 47.9% |
| Non-GAAP OpMgn | 4.1% | -0.3% | 3.0% | 7.9% | 10.8% | 15.0% | 18.7% | 25.2% | 32.2% |
| Non-GAAP EPS | $0.29 | $0.06 | $0.18 | $0.42 | $0.57 | $0.88 | $1.10 | $1.67 | $2.37 |
| Adj EBITDA | $41.0M | $25.9M | $37.0M | $57.6M | $71.0M | $98.7M | $127.6M | $198.3M | $293.5M |
| FCF | ($26.6M) | $10.9M | ($34.5M) | ($15.9M) | ($64.4M) | $10.1M | ($18.3M) | $43.1M | $79.1M |
Acceleration / Deceleration Assessment
Revenue: ACCELERATING. YoY growth stepped from +16% to +90% over 5 comparable quarters. Every sequential quarter showed acceleration in the YoY growth rate -- a classic demand-pull pattern in a supply-constrained environment. Non-GAAP EPS went from $0.06 to $2.37 in 8 quarters (~40x) despite significant share dilution. Operating margins expanded +700 bps in the most recent quarter alone, with management guiding to 35-36% for Q4 FY2026.
Balance Sheet Transformation
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | CQ1 '26 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $774.3M | $1,290.2M | $859.0M | $436.7M | $520.7M | $2,617.8M |
| Convertible Notes | $789.8M | $1,466.1M | $2,500.0M | $2,503.2M | $2,562.6M | $43.2M |
| Net Cash / (Debt) | ($15.5M) | ($175.9M) | ($1,641.0M) | ($2,066.5M) | ($2,041.9M) | $2,574.6M |
| Total Equity | $1,972.8M | $1,875.0M | $1,355.8M | $957.3M | $1,134.7M | $2,973.4M |
| Total Assets | $3,551.6M | $4,162.2M | $4,632.1M | $3,931.9M | $4,218.7M | $7,027.9M |
Extraordinary deleveraging in 18 months. The ~$2.5B convertible debt burden that weighed on the company from FY2023-FY2025 has been nearly entirely retired (down to $43.2M) via conversions as the stock surged. The NVIDIA strategic investment brought cash to $2,617.8M. Net cash position swung from roughly ($2.0B) at FY2024 to approximately $2.6B -- a fortress balance sheet providing ample firepower for the aggressive CapEx cycle ahead.
Capital Allocation
Dividends & Buybacks: Lumentum pays no dividend and has not been executing share repurchases during the current investment cycle. The company is prioritizing aggressive CapEx deployment over shareholder returns -- rational given the magnitude of the opportunity.
Strategic Dilution (NVIDIA): Diluted shares expanded from 67.3M (FY2024) to 96.2M (CQ1 2026), a ~43% increase. The primary drivers: (1) NVIDIA's ~$2B direct equity investment in Q3 FY2026, and (2) convertible note conversions as the stock appreciated above conversion prices. This dilution was strategic and value-accretive -- it brought in $2B in cash, aligned with the company's largest customer, and eliminated $2.5B in debt.
M&A: Cloud Light acquisition (~$750M, CQ4 2023) built the transceiver/module business. NeoPhotonics (prior acquisition) added narrow linewidth laser technology. In March 2026, acquired a fifth indium phosphide fab in Greensboro, NC to expand CPO laser capacity. Divested non-core businesses (metrology, x-ray) in FY2025 to sharpen AI/cloud focus.
CapEx Reinvestment: CapEx accelerated from $84.8M (FY2021) to $231.0M (FY2025), running at ~$285M annualized through 3Q of FY2026. Investment focused on indium phosphide wafer fab expansion (Japan and U.S.), Thailand module manufacturing, and OCS capacity. Customer LTAs with prepayment and take-or-pay terms help underwrite CapEx risk.
Red Flags Assessment
| Flag | Status | Detail |
|---|---|---|
| Negative FCF | Transitional | FY2024 FCF ($108.3M) and FY2025 ($104.7M) were negative, but driven by deliberate investment cycle (CapEx 2-3x prior levels). CQ1 '26 generated $79.1M in quarterly FCF with OCF of $203.8M -- inflecting strongly positive. Not structural. |
| Share Dilution >10% YoY | Strategic | Shares grew ~34% in 3 quarters (72.0M to 96.2M). Bulk from NVIDIA investment (~$2B cash in) and convertible conversions (eliminated ~$2.5B debt). Ongoing SBC at ~$170M/yr (~17% of non-GAAP NI, declining as earnings scale). |
| Revenue/Income Divergence | Not Flagged | The opposite: revenue grew +90% YoY in CQ1 '26 while non-GAAP operating income grew ~17x ($15.0M to $260.7M). Operating leverage is extremely strong. |
| Debt Growing Faster than Rev | Not Flagged | Convertible notes declined from $2,562.6M to $43.2M over 4 quarters while revenue surged. Financial debt is near zero. |
Forward Model (FY2026E -- FY2030E)
| Metric | FY2025A | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|---|
| Revenue | $1,655M | $3,010M | $5,000M | $8,000M | $10,000M | $11,200M |
| YoY Growth | +21% | +82% | +66% | +60% | +25% | +12% |
| Non-GAAP GM | 34.7% | 44.5% | 48.0% | 51.0% | 52.0% | 52.5% |
| Non-GAAP OpMgn | 9.7% | 29.0% | 35.0% | 40.0% | 41.5% | 42.0% |
| Non-GAAP EPS | $2.06 | $8.10 | $16.50 | $30.00 | $38.00 | $43.00 |
| Diluted Shares (M) | 71M | 95M | 102M | 105M | 107M | 108M |
| Est. FCF | ~($60M) | ~$355M | ~$975M | ~$2,375M | ~$3,625M | ~$4,350M |
| FCF Margin | (3.6%) | 11.8% | 19.5% | 29.7% | 36.3% | 38.8% |
FY2026E: Q1 $534M + Q2 $666M + Q3 $808M + Q4 $985M (guided midpoint). FY2027E assumes quarterly trajectory from ~$1.05B to ~$1.45B, consistent with management's $1.25B/qtr milestone. FY2028E consistent with management's $2B/qtr "North Star" target. Margin drivers: EML/component mix, pricing power, 200G ASP uplift, OCS above-average margins, factory utilization, CW laser insourcing. CapEx peaks FY2027-28 at 15-19% of revenue, then declines to 5-7%.
Scenario Summary (3-year targets): Bull case (25% weight): $12.0B FY2029 revenue, $48 EPS, $1,975 target (+109%). Base case (50%): $10.0B revenue, $38 EPS, $1,250 target (+32%). Bear case (25%): $6.5B revenue, $18 EPS, $450 target (-52%). Probability-weighted target: ~$1,230 (+30%, ~9% annualized IRR). The key swing factor is whether AI CapEx sustains through CY2028-29 and Lumentum executes on OCS + CPO simultaneously.
Through-Cycle Quality Narrative
Lumentum's financial history reveals a deeply cyclical semiconductor/optical components business undergoing a genuine structural inflection. The bear case prior to AI was clear: a company with 50%+ gross margins at peak (FY2021-22) that saw margins compress to 33% at trough, lost money on a GAAP basis for two consecutive years, and generated negative FCF while carrying $2.5B in convertible debt.
The AI-driven recovery has answered nearly every concern. Revenue scale is breaking through -- $808M quarterly with a path to $2B/quarter within 2-3 years. The diversity of growth drivers (EMLs, pump lasers, CW lasers, OCS, CPO, transceivers) across multiple hyperscale customers reduces single-product and single-customer risk. Non-GAAP gross margins of 47.9% are approaching prior-peak levels despite a lower-margin transceiver business in the mix. Operating margins of 32.2% have already surpassed the FY2021-22 peak of 30.8%.
Competitive moats are strengthening: supply constraints across the portfolio (>30% imbalance on EMLs, even greater on pumps) with capacity expansion gated by indium phosphide fab buildout timelines provide 12-18 months of pricing power and margin protection. Customer LTAs with prepayment and take-or-pay terms reduce revenue risk.
The key question for a decade-long view is whether Lumentum can sustain 40%+ gross margins and 25%+ operating margins when AI infrastructure spending inevitably moderates from its current torrid pace. The structural demand driver (AI optical interconnect) appears durable and multi-year, but the business has not yet demonstrated resilience through an AI spending downcycle. Cash conversion recovered to 90% in CQ1 '26 from a 36% trough in FY2024, and the fortress balance sheet (~$2.6B net cash) provides a buffer that did not exist in prior cycles.
Data sourced from Daloopa and Lumentum Holdings earnings releases (FY2021 through Q3 FY2026). All financials in USD. Fiscal year ends late June. Forward estimates based on management guidance (OFC March 2026) and internal modeling.